A supply deal for NUBEQA was finalized between ORIC Pharmaceuticals and BAYER after talks with the FDA.

The entities involved

• FDA →
  • The FDA approved Miplyffa for the treatment of Niemann-Pick disease.Sat 00:55
  • iRhythm Technologies launched its Zio ECG system in Japan following FDA clearance, amid reports that Trump-era tariffs benefit AI stocks.Fri 23:50
• BAYER →

  company in Prague, Czechia

  • Dr. Andrea Maier-Richter was appointed Head of Coatings & Adhesives at Bayer AG, succeeding Thomas Römer.Fri 13:20
  • ECB rate rise odds increase due to inflation, while Bayer raises profit forecast and geopolitical tensions persist.Tue 23:52

Related events

• FDA failed to update warning labels despite confirmed risks associated with a product.Fri 08:11
• FDA approval supports NDA submission in Aurora.Oct 23
• Merck announced on September 3, 2025, that it is seeking potential approval for new drugs from the FDA.Jun 7
• A company has entered into a non-clinical evaluation agreement with NIAID, partnering with AFRRI on protocol design that meets FDA Animal Rule criteria.Jun 25
• FDA reviewed an NDA and entered a clinical study agreement for a babesiosis trial involving 60 Degrees Pharmaceuticals.Jun 7